Human papillomavirus-like particles vaccine efficiently produced in a non-fermentative system based on insect larva.
Millán
Alicia Fernández-San
AF
Instituto de Agrobiotecnología (Universidad Pública de Navarra-CSIC-Gobierno de Navarra), Campus Arrosadía, 31006 Pamplona, Spain.
Gómez-Sebastián
Silvia
S
Nuñez
María C
MC
Veramendi
Jon
J
Escribano
José M
JM
D000818:Animals; D016367:Baculoviridae / Q000235:genetics; D036022:Capsid Proteins / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D002460:Cell Line; D005260:Female; D015870:Gene Expression; D005822:Genetic Vectors; D052162:Human papillomavirus 16 / Q000276:immunology*; D006801:Humans; D007313:Insecta / Q000235:genetics / Q000821:virology; D007814:Larva / Q000235:genetics / Q000821:virology; D051379:Mice; D008807:Mice, Inbred BALB C; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000276:immunology*
D036022:Capsid Proteins; D009856:Oncogene Proteins, Viral; D053918:Papillomavirus Vaccines; C063317:L1 protein, Human papillomavirus type 16